| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 8.189 | 8.818 | 6.436 | 3.481 | 3.625 | 3.473 | 0 | 0 | 44.783 | 59.238 |
| Total Income - EUR | 8.189 | 8.818 | 6.436 | 3.481 | 3.625 | 3.473 | 0 | 0 | 44.783 | 59.239 |
| Total Expenses - EUR | 6.522 | 5.129 | 3.205 | 1.683 | 5.672 | 1.617 | 0 | 0 | 16.109 | 53.366 |
| Gross Profit/Loss - EUR | 1.667 | 3.689 | 3.231 | 1.798 | -2.047 | 1.856 | 0 | 0 | 28.674 | 5.873 |
| Net Profit/Loss - EUR | 1.422 | 3.424 | 3.038 | 1.694 | -2.156 | 1.760 | 0 | 0 | 28.248 | 4.362 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Kerszmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39.433 | 66.418 |
| Current Assets | 2.715 | 4.416 | 4.515 | 6.136 | 3.807 | 5.504 | 5.363 | 5.379 | 38.805 | 83.215 |
| Inventories | 1.859 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33.891 | 78.946 |
| Cash | 855 | 4.416 | 4.515 | 6.136 | 3.807 | 5.504 | 5.363 | 5.379 | 4.914 | 4.269 |
| Shareholders Funds | 700 | 4.117 | 4.458 | 6.070 | 3.797 | 5.484 | 5.363 | 5.379 | 33.611 | 4.414 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.015 | 299 | 56 | 66 | 10 | 20 | 0 | 62 | 44.689 | 145.280 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Kerszmed Srl